+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Implantable Drug Delivery Device Market by Product Type, Application, End User, Technology - Global Forecast to 2030- Product Image
Implantable Drug Delivery Device Market by Product Type, Application, End User, Technology - Global Forecast to 2030- Product Image
Sale

Implantable Drug Delivery Device Market by Product Type, Application, End User, Technology - Global Forecast to 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904899
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Implantable Drug Delivery Device Market grew from USD 21.53 billion in 2024 to USD 23.49 billion in 2025. It is expected to continue growing at a CAGR of 8.95%, reaching USD 36.01 billion by 2030.

Revolutionizing Treatment Through Precision Implantable Drug Delivery

Implantable drug delivery devices represent a paradigm shift in chronic disease management, enabling targeted therapy with sustained release kinetics that reduce systemic side effects. These advanced platforms integrate material science, microelectronics, and pharmaceutics to deliver medication at controlled rates, offering patients greater convenience and improved adherence compared to traditional systemic administration.

The confluence of engineering innovation and pharmacological expertise has birthed a new generation of devices ranging from programmable microchip implants to osmotic pumps. As healthcare providers strive for personalized medicine, these systems facilitate bespoke dosing regimens while minimizing hospital visits. Emerging materials such as biodegradable polymers further enhance biocompatibility and reduce the need for device retrieval, underscoring the dynamic evolution of this sector.

This executive summary distills key market drivers, transformative trends, and regulatory influences shaping the industry. It examines segmentation by product type, application, end user, and technology before exploring regional dynamics and competitive landscapes. In addition, it addresses tariff implications, delivers actionable recommendations for decision makers, and outlines the rigorous methodology underpinning the research

Emerging Paradigms Redefining Drug Delivery Landscapes

Over the past decade, the implantable drug delivery space has undergone radical transformation driven by convergence of smart engineering and digital health. Traditional osmotic shrink-wrapped pumps have ceded ground to microchip-based platforms that allow real-time titration of therapeutic payloads. Integration of sensor arrays and wireless communication protocols enables remote monitoring and adaptive dosing, empowering clinicians to refine therapy regimens without additional procedures.

In parallel, advances in biodegradable polymers have facilitated the development of fully resorbable implants that obviate device retrieval surgeries and reduce long-term complications. Simultaneously, infusion pumps have diversified into specialized chemotherapy and pain management configurations, offering high precision in oncology and chronic disease frameworks.

Regulatory bodies are adapting frameworks to accommodate these innovations, expediting approval paths through breakthrough device designations and harmonizing standards across regions. With artificial intelligence and data analytics emerging as critical enablers, companies are poised to harness predictive modeling to optimize device performance and patient outcomes

Tariff Dynamics Shaping the US Implantable Device Market

The implementation of cumulative tariff measures in 2025 has introduced a new variable for manufacturers and suppliers within the United States. Levies on critical raw materials, including medical-grade stainless steel and electronic components, have elevated production costs and compressed profit margins across the supply chain. These changes have compelled device developers to reevaluate sourcing strategies and reined in manufacturing costs while maintaining stringent quality standards.

In response, several global players have accelerated plans to establish or expand domestic production facilities, seeking to mitigate exposure to import duties. At the same time, cross-border partnerships and toll manufacturing arrangements have emerged as viable tactics to balance tariff burdens without compromising scale. These alternative models of collaboration are reshaping traditional trade flows and fostering resilience against future policy shifts.

Despite the headwinds, proactive companies are leveraging modular design frameworks to standardize components across multiple devices, reducing complexity and optimizing inventory management. As a result, the market is expected to see an infusion of cost-efficient solutions that preserve clinical differentiation while adapting to the new tariff environment

Revealing Key Market Segments Driving Growth

A granular analysis by product type reveals that contraceptive implants continue to lead adoption by offering long-acting reversible contraception with minimal patient maintenance. Drug eluting stents, spanning both coronary and peripheral indications, have sustained momentum through enhanced drug coatings and novel scaffold materials that inhibit restenosis. Infusion pumps bifurcate into chemotherapy, insulin and pain management modalities, each tailored to the unique pharmacokinetic demands of respective therapies. Parallel innovations in microchip implants leverage electromechanical pump mechanisms and MEMS systems to achieve programmable release profiles, while osmotic pumps provide passive, continuous drug delivery without external power sources. This breadth of product options underscores the sector’s commitment to customizing therapeutic solutions to diverse clinical needs.

On the application front, cardiology drives significant uptake given the critical role of stents and infusion therapies in vascular interventions, whereas diabetes management through insulin pump technologies remains a high-growth segment. Contraception, neurology and oncology applications benefit from dedicated implant strategies that enhance drug bioavailability in target tissues. Pain management also represents a key area, with specialized pumps enabling localized analgesia for chronic conditions.

End users span the continuum of care from home environments where patient-centric devices empower self-administration, to hospitals performing complex interventional procedures, and specialty clinics focusing on niche therapeutic protocols. Technological segmentation highlights the transition toward biodegradable polymer platforms for degradable implants, mechanical pumps for robust performance, microchip-based systems for intelligent control, and osmotic devices for steady-state release. This multi-dimensional segmentation framework illuminates areas where innovation and market demand align most strongly

Regional Dynamics Influencing Global Adoption Patterns

The Americas command a dominant presence in the implantable device market, buoyed by well-established healthcare infrastructure and progressive reimbursement models. Growth in the United States is underpinned by an emphasis on minimally invasive procedures and a willingness to invest in premium technologies that enhance patient outcomes. Canada’s market expansion is driven by public health initiatives targeting chronic disease management, further reinforcing North America’s leadership position.

In Europe, Middle East & Africa, regulatory harmonization efforts aim to streamline approvals across member states, though varied healthcare funding mechanisms create a mosaic of adoption rates. Western European countries emphasize cost-effectiveness and clinical evidence, while emerging economies in the Middle East and Africa pursue capacity-building partnerships to introduce advanced therapeutic options. This region’s heterogeneity presents both challenges and opportunities for device innovators.

Asia-Pacific offers one of the most dynamic growth landscapes, propelled by rising incidences of cardiovascular disease, diabetes and cancer. Governments in key markets such as China, India and Australia are expanding reimbursement networks and incentivizing local manufacturing to reduce dependency on imports. Rapid urbanization and increasing healthcare expenditure support the introduction of advanced drug delivery platforms across public and private sectors, making the region indispensable to long-term market forecasts

Competitive Landscape and Strategic Innovators in View

The competitive landscape in implantable drug delivery is characterized by a mix of established medical device giants and agile start-ups. Leading industry participants have fortified their portfolios through targeted acquisitions of specialty pump developers and strategic partnerships with biotechnology firms. This consolidation trend has intensified research efforts in areas such as polymeric drug reservoirs and integrated sensor-actuator systems, enabling players to differentiate through technological depth.

Emerging companies are carving out niches by concentrating on microelectronic enhancements and software-driven delivery algorithms that align with telehealth platforms. Their collaborations with academic institutions accelerate proof-of-concept milestones, allowing rapid progression from bench to clinical evaluation. This dual-track approach balances the scale of legacy manufacturers with the innovation speed of disruptors, fostering a competitive environment that benefits end users.

Across the board, vendors are investing in supply chain resilience by diversifying component sourcing and adopting additive manufacturing for rapid prototyping. Emphasis on quality management systems and compliance frameworks positions these companies to navigate evolving regulatory requirements while maintaining market agility. As the field matures, sustained differentiation will hinge on the ability to integrate data analytics, patient feedback and iterative design improvements into next-generation devices

Strategic Pathways to Drive Competitive Advantage

Industry leaders should prioritize the localization of manufacturing operations to reduce exposure to tariff fluctuations and enhance supply chain control. Establishing regional hubs with modular production lines will enable flexible scalability in response to market demand shifts without incurring significant retooling costs.

Collaborative alliances with technology providers and academic research centers can accelerate the development of advanced materials such as smart polymers and responsive microelectronic components. By co-investing in early-stage innovation, companies can secure intellectual property positions and expedite time-to-market for differentiated delivery platforms.

Integrating digital frameworks that collect real-world performance data and patient-reported outcomes offers a dual benefit of optimizing therapeutic efficacy and supporting reimbursement dossiers. Deploying secure connectivity solutions and leveraging predictive analytics will allow manufacturers to refine device parameters post-launch, fostering a continuous improvement cycle that strengthens market positioning.

To further enhance patient engagement, organizations should design user-centric interfaces and intuitive control mechanisms that reduce the learning curve associated with implantable devices. Tailored training and support programs for clinicians and patients will drive adoption rates and generate valuable feedback loops for subsequent product iterations

Methodological Rigor Underlying Market Intelligence

The insights presented in this report result from a structured approach combining primary research with extensive secondary validation. Primary inputs include in-depth interviews with industry executives, regulatory authorities and key opinion leaders across cardiology, oncology and endocrinology domains. These firsthand perspectives illuminate real-world challenges and emerging requirements that quantitative data alone cannot capture.

Secondary analysis draws upon peer-reviewed publications, regulatory filings, patent databases and proprietary company reports. Cross-referencing diverse data sources ensures consistency and helps identify discrepancies in publicly available information. A systematic triangulation process harmonizes differing viewpoints, yielding a robust dataset that reflects both market conditions and technological advancements.

Rigorous quality controls are enforced through advisory board reviews and statistical validation techniques. Data points undergo outlier analysis and sensitivity testing to confirm reliability under various scenarios. This methodological framework provides confidence that the conclusions and recommendations are grounded in empirical evidence and expert consensus

Closing Reflections on the Evolution of Drug Delivery

The implantable drug delivery market is at an inflection point, driven by technological breakthroughs and evolving healthcare paradigms. As patient populations grow and treatment regimens become more complex, the demand for precision delivery systems that balance efficacy and safety will intensify. Companies that harness interdisciplinary innovation while navigating regulatory landscapes will emerge as frontrunners in this competitive arena.

The integration of digital health capabilities, such as telemetry-enabled devices and predictive maintenance algorithms, signals a shift toward holistic solution offerings. Stakeholders must align development pipelines with emerging clinical needs and reimbursement frameworks to secure sustainable market access. By fostering transparent collaboration among industry, academia and regulators, the sector can accelerate the translation of novel concepts into life-changing therapies

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Contraceptive Implants
    • Drug Eluting Stents
      • Coronary Stents
      • Peripheral Stents
    • Infusion Pumps
      • Chemotherapy Pumps
      • Insulin Pumps
      • Pain Management Pumps
    • Microchip Implants
    • Osmotic Pumps
  • Application
    • Cardiology
    • Contraception
    • Diabetes
    • Neurology
    • Oncology
    • Pain Management
  • End User
    • Home Care
    • Hospitals
    • Specialty Clinics
  • Technology
    • Biodegradable Polymers
    • Mechanical Pumps
    • Microchip Based
      • Electromechanical Pumps
      • MEMS Systems
    • Osmotic Pumps
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Medtronic plc
  • Flowonix Medical, Inc.
  • Tricumed Medical Technology GmbH
  • Debiotech SA
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Smiths Group plc
  • Terumo Corporation
  • Fresenius Kabi AG
  • Pfizer Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Implantable Drug Delivery Device Market, by Product Type
8.1. Introduction
8.2. Contraceptive Implants
8.3. Drug Eluting Stents
8.3.1. Coronary Stents
8.3.2. Peripheral Stents
8.4. Infusion Pumps
8.4.1. Chemotherapy Pumps
8.4.2. Insulin Pumps
8.4.3. Pain Management Pumps
8.5. Microchip Implants
8.6. Osmotic Pumps
9. Implantable Drug Delivery Device Market, by Application
9.1. Introduction
9.2. Cardiology
9.3. Contraception
9.4. Diabetes
9.5. Neurology
9.6. Oncology
9.7. Pain Management
10. Implantable Drug Delivery Device Market, by End User
10.1. Introduction
10.2. Home Care
10.3. Hospitals
10.4. Specialty Clinics
11. Implantable Drug Delivery Device Market, by Technology
11.1. Introduction
11.2. Biodegradable Polymers
11.3. Mechanical Pumps
11.4. Microchip Based
11.4.1. Electromechanical Pumps
11.4.2. MEMS Systems
11.5. Osmotic Pumps
12. Americas Implantable Drug Delivery Device Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Implantable Drug Delivery Device Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Implantable Drug Delivery Device Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Medtronic plc
15.3.2. Flowonix Medical, Inc.
15.3.3. Tricumed Medical Technology GmbH
15.3.4. Debiotech SA
15.3.5. Baxter International Inc.
15.3.6. B. Braun Melsungen AG
15.3.7. Smiths Group plc
15.3.8. Terumo Corporation
15.3.9. Fresenius Kabi AG
15.3.10. Pfizer Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. IMPLANTABLE DRUG DELIVERY DEVICE MARKET MULTI-CURRENCY
FIGURE 2. IMPLANTABLE DRUG DELIVERY DEVICE MARKET MULTI-LANGUAGE
FIGURE 3. IMPLANTABLE DRUG DELIVERY DEVICE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. IMPLANTABLE DRUG DELIVERY DEVICE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. IMPLANTABLE DRUG DELIVERY DEVICE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. IMPLANTABLE DRUG DELIVERY DEVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CONTRACEPTIVE IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CORONARY STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PERIPHERAL STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CHEMOTHERAPY PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PAIN MANAGEMENT PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY OSMOTIC PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CONTRACEPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MECHANICAL PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY ELECTROMECHANICAL PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MEMS SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY OSMOTIC PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 54. CANADA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55. CANADA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 56. CANADA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 57. CANADA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. CANADA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. CANADA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. CANADA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 61. MEXICO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. MEXICO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 63. MEXICO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 64. MEXICO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. MEXICO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. MEXICO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 67. MEXICO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. UNITED KINGDOM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 92. UNITED KINGDOM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 97. GERMANY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. GERMANY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 99. GERMANY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 100. GERMANY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. GERMANY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. GERMANY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. GERMANY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 104. FRANCE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 105. FRANCE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 106. FRANCE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 107. FRANCE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. FRANCE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. FRANCE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. FRANCE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. RUSSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 113. RUSSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 114. RUSSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 118. ITALY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. ITALY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 120. ITALY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 121. ITALY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. ITALY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. ITALY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. ITALY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 125. SPAIN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. SPAIN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 127. SPAIN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 128. SPAIN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. SPAIN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. SPAIN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. SPAIN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. UNITED ARAB EMIRATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 134. UNITED ARAB EMIRATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 135. UNITED ARAB EMIRATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. SAUDI ARABIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 141. SAUDI ARABIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 142. SAUDI ARABIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. SAUDI ARABIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. SAUDI ARABIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. SAUDI ARABIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. SOUTH AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 148. SOUTH AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 149. SOUTH AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. SOUTH AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. SOUTH AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. SOUTH AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 153. DENMARK IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. DENMARK IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 155. DENMARK IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 156. DENMARK IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. DENMARK IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. DENMARK IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. DENMARK IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 167. QATAR IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. QATAR IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 169. QATAR IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 170. QATAR IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. QATAR IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. QATAR IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. QATAR IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 174. FINLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 175. FINLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 176. FINLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 177. FINLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. FINLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. FINLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 180. FINLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 183. SWEDEN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 184. SWEDEN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. SWEDEN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. SWEDEN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. SWEDEN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. NIGERIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 190. NIGERIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 191. NIGERIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. NIGERIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. NIGERIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. NIGERIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 195. EGYPT IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 196. EGYPT IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 197. EGYPT IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 198. EGYPT IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. EGYPT IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. EGYPT IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 201. EGYPT IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 202. TURKEY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 203. TURKEY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 204. TURKEY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 205. TURKEY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. TURKEY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. TURKEY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 208. TURKEY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 216. NORWAY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. NORWAY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 218. NORWAY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 219. NORWAY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. NORWAY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. NORWAY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 222. NORWAY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 223. POLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. POLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 225. POLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 226. POLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. POLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. POLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 229. POLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 231. SWITZERLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 232. SWITZERLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 233. SWITZERLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. SWITZERLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. SWITZERLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 236. SWITZERLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 244. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 245. CHINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. CHINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 247. CHINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 248. CHINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. CHINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. CHINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. CHINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 252. INDIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. INDIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 254. INDIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 255. INDIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. INDIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. INDIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 258. INDIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 259. JAPAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 260. JAPAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 261. JAPAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 262. JAPAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. JAPAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. JAPAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 265. JAPAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 272. AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 275. SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 276. SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 279. SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 283. INDONESIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. INDONESIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. INDONESIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 286. INDONESIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 287. THAILAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 288. THAILAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 289. THAILAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 290. THAILAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 291. THAILAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. THAILAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 293. THAILAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 295. PHILIPPINES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 296. PHILIPPINES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 297. PHILIPPINES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 298. PHILIPPINES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. PHILIPPINES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 300. PHILIPPINES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROCHIP BASED, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 303. MALAY

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Implantable Drug Delivery Device market report include:
  • Medtronic plc
  • Flowonix Medical, Inc.
  • Tricumed Medical Technology GmbH
  • Debiotech SA
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Smiths Group plc
  • Terumo Corporation
  • Fresenius Kabi AG
  • Pfizer Inc.

Table Information

Report AttributeDetails
No. of Pages180
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 23.49 Billion
Forecasted Market Value ( USD ) by 2030 $ 36.01 Billion
Compound Annual Growth Rate8.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Implantable Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product, By Type (Biodegradable, Nonbiodegradable), By Technology, By Application, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Implantable Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product, By Type (Biodegradable, Nonbiodegradable), By Technology, By Application, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Implantable Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Implantable Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Implantable Drug Delivery Devices Market Report 2025 - Product Image

Implantable Drug Delivery Devices Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Implantable Drug Delivery Devices - Global Strategic Business Report - Product Image

Implantable Drug Delivery Devices - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Implantable Drug Delivery Devices Market 2025-2033 - Product Image

Implantable Drug Delivery Devices Market 2025-2033

  • Report
  • 144 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.